SURVEY OF HUMAN LEUKOCYTE ANTIGEN BY PCR-SSO METHOD AND ABO - RHESUS BLOOD GROUP BY GELCARD METHOD IN PATIENTS WITH CHRONIC RENAL FAILURE WAITING FOR KIDNEY TRANSPLANTATION AND DONORS AT CHO RAY HOSPITAL

Thị Thu Hà Phan1, , Thanh Tùng Trần1, Thị Mỹ Duyên Trần1, Lê Nhật Minh Phạm1, Quốc Việt Võ1, Thị Thoan Đào1, Thị Cảm Nguyễn1, Thị Thu Hằng Thân1, Hoàng Oanh Lê2
1 Bệnh viện Chợ Rẫy
2 Trường Đại học Quốc tế Hồng Bàng

Main Article Content

Abstract

Introduction: The success of kidney transplantation depends not only on surgical techniques but also on immunological compatibility between donors and recipients. Among the key determinants, compatibility of human leukocyte antigens (HLA) and the ABO and Rhesus (Rh) blood group systems plays a crucial role in reducing the risk of graft rejection and improving long-term graft survival. Investigating the distribution of HLA alleles together with ABO and Rh blood groups in kidney donors and recipients is important for optimizing donor–recipient matching, improving transplantation outcomes, and establishing a national database to support organ transplantation in Vietnam.


Materials and Methods: A cross-sectional descriptive study was conducted on 446 blood samples, including patients with chronic kidney disease awaiting kidney transplantation and kidney donors. HLA typing was performed using polymerase chain reaction with sequence-specific oligonucleotide probes (PCR-SSO) method, and ABO–Rhesus blood grouping was determined at the Blood Transfusion Center, Cho Ray Hospital, between January 2023 and September 2024.


Results: The distribution of ABO blood groups was O (49.33%), B (27.35%), A (18.39%), and AB (4.93%). Rh-positive and Rh-negative blood groups accounted for 99.55% and 0.45%, respectively. A high degree of HLA polymorphism was observed, with 14 HLA-A alleles, 23 HLA-B alleles, 13 HLA-DRB1 alleles, 6 HLA-DQA1 alleles, and 5 HLA-DQB1 alleles identified. The most frequent HLA alleles were A*02 (25.67%), A*11 (24.78%), B*15 (25.45%), B*07 (10.76%), DRB1*12 (29.82%), DRB1*09 (12.78%), DQA1*01 (35.09%), DQA1*06 (24.55%), DQB1*03 (50.90%), and DQB1*05 (27.02%). The most common HLA allele combinations were A11–B15 (7.34%), DRB112–DQA106 (15.47%), DRB112–DQB103 (21.36%), and DQA101–DQB105 (18.05%).


Conclusions: HLA antigens demonstrated substantial polymorphism among the study population. The most prevalent alleles were HLA- A*02, A*11, B*15, DRB1*12, DQA1*01, and DQB1*03. The most common HLA allele combinations included HLA- A*11-B*15, DRB1*12-DQA1*06, DRB1*12-DQB1*03, and DQA1*01-DQB1*05.

Article Details

References

1. Hoàng Giang, và cộng sự (2021), Nghiên cứu đặc điểm người bệnh chạy thận nhân tạo tại 26 bệnh viện của Hà Nội năm 2020. Ministry of Science and Technology Vietnam, 63(5), tr.17-21.
2. Nguyễn Vân Hương, và cộng sự (2024), Đánh giá tác động của HLA typ I và kháng thể kháng HLA trên bệnh nhân ghép thận TNU Journal of Science and Technology, 230(01), tr.267-72.
3. Nguyễn Vân Hương, và cộng sự (2023), Khảo sát genotype của kháng nguyên bạch cầu người lớp II ở bệnh nhân suy thận. TNU Journal of Science and Technology, 228(13), tr.432-7.
4. Lê Nguyên Vũ, và cộng sự (2024), Đặc điểm kháng nguyên hệ HLA và độ hòa hợp HLA ở cặp bệnh nhân cho - nhận thận cùng huyết thống tại Bệnh viện Hữu Nghị Việt Đức. Tạp Chí Y học Việt Nam, 538(3), tr.181-5.
5. Arrieta-Bolanos, E., et al. (2023), An HLA map of the world: A comparison of HLA frequencies in 200 worldwide populations reveals diverse patterns for class I and class II. Front Genet, 14, pp.866407.
6. Creary, Lisa E., et al. (2021), High-resolution HLA allele and haplotype frequencies in several unrelated populations determined by next generation sequencing: 17th International HLA and Immunogenetics Workshop joint report. Hum Immunol, 82(7), pp.505-22.
7. Hieu, Ho Trung, et al. (2019), Association of Human Leukocyte Antigen Haplotypes With End-Stage Renal Disease in Vietnamese Patients Prior to First Transplantation. Transplant Proceedings, 51(8), pp.2549-54.
8. Lehmann, Claudia, et al. (2023), Extended genomic HLA typing identifies previously unrecognized mismatches in living kidney transplantation. Front Immunol, 14, pp.1094862.